Biopharma Advisory is a founder-led boutique advisory firm supporting biotech, pharma, and medtech companies with non-executive board-level strategic guidance across growth, financing, and governance topics.

The firm is led by Dr. Alexandra Goll, a certified Non-Executive Board Member and ESG expert (SAIF-NE, QAIF / Deutsche Börse), with over 30 years of experience in the global life sciences industry — spanning operational leadership, venture capital, IPOs, and M&A.

Biopharma Advisory supports:

✔︎ Non-Executive Board Mandates, Supervisory & Advisory Board Seats
✔︎ Strategic board-level consulting on positioning, M&A, and IPOs
✔︎ Governance and ESG integration aligned with capital markets
✔︎ Investor readiness & stakeholder engagement
✔︎ Cross-border transaction support for licensing, M&A, and fundraising
✔︎ Investment advisory for generalist Private Equity and Venture Capital Funds or Family Offices with an interest in the life sciences sector

Dr. Goll brings over 30 years of experience in the life sciences sector, including:
✔︎ Former Managing & General Partner at TVM Capital Life Science
✔︎ Head of Business Development at Calliditas Therapeutics AB (acquired by Asahi Kasei in 2024)
✔︎ Board-side strategic advisor at FCF Fox Corporate Finance

Through active board roles and hands-on advisory mandates, Biopharma Advisory helps clients build long-term value, navigate complexity, and meet the highest standards of governance and growth.

Whether as a Non-Executive Board Member, an advisor to the C-suite, or a partner to investors, Alexandra offers the rare combination of strategic, operational, and financial expertise.

Biopharma Advisory

Org chart

Teams

Offices

Biopharma Advisory

Org chart

Teams

Offices

Related companies